PRESS RELEASE published on 12/23/2024 at 16:03, 1 year 2 months ago EQS-Adhoc: SNP: Conclusion of an Investment Agreement with Carlyle and Announcement of a Voluntary Public Takeover Offer and Subsequent Delisting SNP Schneider-Neureither & Partner SE concludes an investment agreement with Carlyle, announcing a voluntary public takeover offer and subsequent delisting for strategic growth Delisting Takeover Offer Investment Agreement SNP Schneider-Neureither & Partner SE Carlyle
PRESS RELEASE published on 12/23/2024 at 15:58, 1 year 2 months ago EQS-WpÜG: Takeover Offer / Target company: SNP Schneider-Neureither & Partner SE; Bidder: Succession German Bidco GmbH Succession German Bidco GmbH, controlled by Carlyle, will make a voluntary public takeover offer for SNP Schneider-Neureither & Partner SE. The offer price is EUR 61.00 per share Takeover Offer SNP Schneider-Neureither & Partner SE Carlyle Succession German Bidco GmbH EUR 61.00
BRIEF published on 11/07/2024 at 07:10, 1 year 4 months ago SNP Reports Robust Growth in Third Quarter 2024 Revenue Increase Market Expansion Q3 2024 Results SNP Growth EXA Segment
PRESS RELEASE published on 11/07/2024 at 07:05, 1 year 4 months ago SNP confirms preliminary figures for the third quarter 2024 and remains on its growth path SNP confirms strong Q3 2024 results with 24% growth in order entry and revenue. EBIT margin rises to 12.2%. Outlook for 2024 raised. EXA segment shows impressive growth EBIT Margin Outlook Growth Q3 2024 SNP
BRIEF published on 10/16/2024 at 10:52, 1 year 5 months ago SNP Reports Strong Q3 2024 Performance and Raises Annual Guidance Revenue Growth Order Entry EBIT Improvement Guidance Increase SAP Data Management
BRIEF published on 10/16/2024 at 10:49, 1 year 5 months ago SNP Increases 2024 Financial Outlook Revenue Forecast Order Entry Financial Outlook EBIT Increase SNP
PRESS RELEASE published on 10/16/2024 at 10:47, 1 year 5 months ago SNP: Significant Increase of Revenue and Earnings in the Third Quarter – Further Raise of Full-Year Guidance 2024 SNP reports significant increase in revenue and earnings for Q3 2024, raises full-year guidance. Order entry up 24% to €75 million, revenue up 24% to €67 million, EBIT margin at 12% Revenue Earnings Q3 2024 Full-year Guidance SNP
PRESS RELEASE published on 10/16/2024 at 10:44, 1 year 5 months ago EQS-Adhoc: SNP Again Raises Outlook for the Full Year 2024 SNP raises revenue and EBIT outlook for full year 2024 due to strong Q3 performance and market momentum Revenue Forecast Market Momentum SNP Full Year 2024 EBIT Outlook
BRIEF published on 08/08/2024 at 07:35, 1 year 7 months ago SNP Reports Record Q2 2024 Results Driven by Strong Partner Business and Software Sales Financial Performance Q2 2024 Results Software Sales Partner Business SNP Achievements
PRESS RELEASE published on 08/08/2024 at 07:30, 1 year 7 months ago SNP reports record Q2 2024 results driven by strong partner business and software sales SNP reports record Q2 2024 results with increased order entry and revenue, driven by partner business and software sales. EBIT margin rises to 13.6%. Outlook raised for 2024 financial year Q2 2024 Record Results SNP Software Sales Partner Business
Published on 03/16/2026 at 22:30, 8 hours 43 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 9 hours 13 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 9 hours 43 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 10 hours 13 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 07:05, 8 minutes ago Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
Published on 03/17/2026 at 07:03, 10 minutes ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 13 minutes ago PolyPeptide publishes invitation to the annual General Meeting 2026
Published on 03/17/2026 at 07:00, 13 minutes ago Very strong business performance delivered in 2025. Continued growth expected in 2026
Published on 03/17/2026 at 06:59, 14 minutes ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 13 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 13 hours 13 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 13 hours 15 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours 16 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026